Overexpression of lncRNA NLIPMT Inhibits Colorectal Cancer Cell Migration and Invasion by Downregulating TGF-β1
Authors An Y, Zhang S, Zhang J, Yin Q, Han H, Wu F, Zhang X
Received 30 January 2020
Accepted for publication 18 June 2020
Published 20 July 2020 Volume 2020:12 Pages 6045—6052
Checked for plagiarism Yes
Review by Single-blind
Peer reviewer comments 2
Editor who approved publication: Dr Eileen O'Reilly
Yongkang An,1 Shuangxi Zhang,1 Jing Zhang,1 Qing Yin,2 Haitao Han,1 Fang Wu,3 Xiangan Zhang1
1The First Affiliated Hospital of Henan University of TCM, Anorectal Disease Clinic, Zhengzhou City, Henan Province 450000, People’s Republic of China; 2The Affiliated Hospital of Henan Academy of TCM, Nursing Department, Zhengzhou City, Henan Province 450000, People’s Republic of China; 3The First Affiliated Hospital of Henan University of TCM, Medical and Nursing Joint, Zhengzhou City, Henan Province 450000, People’s Republic of China
Correspondence: Xiangan Zhang
The First Affiliated Hospital of Henan University of TCM, Anorectal Disease Clinic, Zhengzhou City, Henan Province 450000, People’s Republic of China
Background: NLIPMT, as a tumor suppressive lncRNA, has only been investigated in breast cancer, while its roles in other types of cancer remain unknown. This study aimed to explore the role of NLIPMT in colorectal cancer (CRC).
Methods: Expression levels of NLIPMT and TGF-β 1 in two types of CRC tissue (Non-tumor tissues and tumor tissues) were measured and compared by qRT-PCR and paired t-test, respectively. Correlations between the expression of NLIPMT and TGF-β 1 were analyzed by performing linear regression. The effects of transfections on cell invasion and migration were evaluated by Transwell assays.
Results: We found that NLIPMT was downregulated, while TGF-β 1 was upregulated in CRC. In CRC tumor, a negative correlation was found between the expression of NLIPMT and TGF-β 1. In CRC cells, overexpression of NLIPMT resulted in downregulation, while silencing of NLIPMT resulted in upregulation of TGF-β 1. Analysis of cell invasion and migration showed that overexpression of NLIPMT suppressed the tumor cell invasion and migration. In contrast, overexpression of TGF-β 1 could promote CRC cell invasion and migration and also reduce the role of NLIPMT. Through the overall survival evaluation, NLIPMT-high groups of CRC represented better survival rate compared to that of the NLIPMT-low group patients.
Conclusion: The expression of lncRNA NLIPMT was negatively correlated with TGF-β 1 in CRC. Overexpression of NLIPMT inhibited the colorectal cancer cell migration and invasion by downregulating TGF-β 1. Furthermore, the expression of NLIPMT in CRC patients predicted better prognosis, which suggested that NLIPMT could be considered as a novel diagnosis biomarker.
Keywords: NLIPMT, colorectal cancer, TGF-β 1, invasion, migration
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]